Skip to main content
Log in

Oral immunization against influenza virus

  • Published:
Archiv für die gesamte Virusforschung Aims and scope Submit manuscript

Summary

Mice and ferrets were immunized by oral, intranasal or intraperitoneal route with attenuated or inactivated influenza A2/Aichi/68. Production of antibodies in groups immunized orally was lower than in groups immunized intranasally or intraperitoneally when attenuated virus was administered. When inactivated virus was inoculated the serum antibody response was high following intraperitoneal injection, low following intranasal injection and nil following oral administration.

Deaths occurred between the 3rd and the 11th day after intranasal immunization with partially attenuated virus, showing that immunization by the intranasal route necessitates more attenuated strains than by oral or by intraperitoneal routes. Higher doses of vaccine were required by oral than intranasal or intraperitoneal route to confer an equivalent degree of protection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexsandrova, G. I.,et al.: Testing the safety and effectiveness of oral administration of a live influenza vaccine. Bull. Wld Hlth Org.42, 429–436 (1970).

    Google Scholar 

  2. Boudreault, A., G. Lussier etV. Pavilanis: Caractères biologiques de souches du virus de l'influenza adaptées à 29°C et à 41°C Canad. J. Microbiol.14, 867–874 (1968).

    Google Scholar 

  3. Boudreault, A., G. Boulay, andV. Pavilanis: Immunization against influenza by oral route. Canad. J. publ. Hlth62, 70 (1970).

    Google Scholar 

  4. Expert Committee on Respiratory Virus Diseases, First Report WHO Tech. Report Series No. 170, pp. 1–59 (1959).

    Google Scholar 

  5. Ikic, D.: Experience in Yugoslavia with live influenza vaccine prepared from an attenuated A2/Hong Kong/68 Strain. Bull. Wld Hlth Org.41, 608–609 (1969).

    Google Scholar 

  6. Kilbourne, E. D.: Future influenza vaccines and the use of genetic recombinants. Bull. Wld Hlth Org.41, 643–645 (1969).

    Google Scholar 

  7. Maassab, H. F., T. Francis, Jr., F. M. Davenport, A. V. Hennessy, E. Minuse, andG. Anderson: Laboratory and clinical characteristics of attenuated strains of influenza virus. Bull. Wld Hlth Org.41, 589–594 (1969).

    Google Scholar 

  8. Mills, J. V., andR. M. Chanock: Temperature-sensitive mutants of influenza virus. I. Behavior in tissue culture and in experimental animals. J. infect. Dis.123, 145–157 (1971).

    Google Scholar 

  9. Smorodincev, A. A.: The effivacy of live influenza vaccines. Bull. Wld Hlth Org.41, 585–588 (1969).

    Google Scholar 

  10. Solov'ev, V. D.: The results of controlled observations on the prophylaxis of influenza with interferon. Bull. Wld Hlth Org.41, 683–688 (1969).

    Google Scholar 

  11. Tyrrell, D. A. J., andA. S. Beare: Some studies on the selection and efficiency of live influenza vaccine viruses. Bull. Wld Hlth Org.41, 581–584 (1969).

    Google Scholar 

  12. Webster, R. G.: Antigenic hybrids of influenza A viruses with surface antigens to order. Virology42, 633–642 (1970).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was partially supported by a grant from National Research Council (915).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boudreault, A., Pavilanis, V. Oral immunization against influenza virus. Archiv f Virusforschung 38, 177–182 (1972). https://doi.org/10.1007/BF01249668

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01249668

Keywords

Navigation